173 related articles for article (PubMed ID: 24130393)
1. Anti B cell targeted therapy for autoimmune hemolytic anemia in an infant.
Makadia D; Siddaiahgari SR; Latha MS
Indian J Pharmacol; 2013; 45(5):526-7. PubMed ID: 24130393
[TBL] [Abstract][Full Text] [Related]
2. Rituximab in steroid refractory autoimmune hemolytic anemia.
Gupta N; Sharma S; Seth T; Mishra P; Mahapatra M; Kumar S; Kapoor R; Agarwal N
Indian J Pediatr; 2012 Jun; 79(6):803-5. PubMed ID: 21830023
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with rituximab of an infant with refractory autoimmune hemolytic anemia.
Moriya K; Matsuhashi T; Onuma M; Niizuma H; Rikiishi T; Asada H; Suzuki J; Sasahara Y; Kure S
Int J Hematol; 2013 Aug; 98(2):237-9. PubMed ID: 23702915
[TBL] [Abstract][Full Text] [Related]
4. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
So MW; Koo BS; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
[TBL] [Abstract][Full Text] [Related]
5. [Are intravenous immunoglobulins useful in severe episodes of autoimmune hemolytic anemia?: Comparative results in 21 episodes from a single centre].
Gil-Fernández JJ; Flores Ballester E; González Martínez M; Arévalo-Serrano J; Tamayo Martín AT; Burgaleta Alonso de Ozalla C
Med Clin (Barc); 2013 Sep; 141(5):201-4. PubMed ID: 22857805
[TBL] [Abstract][Full Text] [Related]
6. Successful induction and maintenance of long-term remission in a child with chronic relapsing autoimmune hemolytic anemia using rituximab.
Gottardo NG; Baker DL; Willis FR
Pediatr Hematol Oncol; 2003; 20(7):557-61. PubMed ID: 12959862
[TBL] [Abstract][Full Text] [Related]
7. [Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].
Ono K; Sato T; Iyama S; Tatekoshi A; Hashimoto A; Kamihara Y; Horiguchi H; Kikuchi S; Takada K; Hayashi T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
Rinsho Ketsueki; 2013 Nov; 54(11):2053-5. PubMed ID: 24305538
[TBL] [Abstract][Full Text] [Related]
8. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children.
Zecca M; Nobili B; Ramenghi U; Perrotta S; Amendola G; Rosito P; Jankovic M; Pierani P; De Stefano P; Bonora MR; Locatelli F
Blood; 2003 May; 101(10):3857-61. PubMed ID: 12531800
[TBL] [Abstract][Full Text] [Related]
9. Severe refractory autoimmune hemolytic anemia with five-year complete hematologic response to third course of treatment with rituximab: a case report.
Abadie K; Hege KM
J Med Case Rep; 2014 Jun; 8():175. PubMed ID: 24889270
[TBL] [Abstract][Full Text] [Related]
10. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients.
Barcellini W; Fattizzo B; Zaninoni A; Radice T; Nichele I; Di Bona E; Lunghi M; Tassinari C; Alfinito F; Ferrari A; Leporace AP; Niscola P; Carpenedo M; Boschetti C; Revelli N; Villa MA; Consonni D; Scaramucci L; De Fabritiis P; Tagariello G; Gaidano G; Rodeghiero F; Cortelezzi A; Zanella A
Blood; 2014 Nov; 124(19):2930-6. PubMed ID: 25232059
[TBL] [Abstract][Full Text] [Related]
11. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
Olfat M; Silverman ED; Levy DM
Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Tuberculosis-Induced Autoimmune Hemolytic Anemia.
Alebbi SM; Kambal A; Abo Samra H; Sharaf Eldean MZ; Mohamed SF; Al-Shokri SD
Am J Trop Med Hyg; 2023 Feb; 108(2):313-316. PubMed ID: 36535253
[TBL] [Abstract][Full Text] [Related]
13. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for treatment of autoimmune hemolytic anemia.
Kuzmanovic M; Jurisic V
Indian Pediatr; 2012 Aug; 49(8):672-4. PubMed ID: 22962244
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of CANOMAD with IVIg and rituximab.
Löscher WN; Woertz A; Wallnöfer M; Wanschitz JV; Luef G
J Neurol; 2013 Apr; 260(4):1168-70. PubMed ID: 23400502
[No Abstract] [Full Text] [Related]
16. Monoclonal antibodies: new therapeutic agents for autoimmune hemolytic anemia?
D'Arena G; Taylor RP; Cascavilla N; Lindorfer MA
Endocr Metab Immune Disord Drug Targets; 2008 Mar; 8(1):62-8. PubMed ID: 18393924
[TBL] [Abstract][Full Text] [Related]
17. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab.
Radhi M; Rumelhart S; Tatman D; Goldman F
J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011
[TBL] [Abstract][Full Text] [Related]
18. Success of anti-CD20 monoclonal antibody treatment for severe autoimmune hemolytic anemia caused by warm-reactive immunoglobulin A, immunoglobulin G, and immunoglobulin M autoantibodies in a child: a case report.
Ajmi H; Mabrouk S; Hassayoun S; Regaieg H; Tfifha M; Jalel C; Skouri H; Zouari N; Abroug S
J Med Case Rep; 2017 Nov; 11(1):321. PubMed ID: 29132419
[TBL] [Abstract][Full Text] [Related]
19. Brucellosis-induced autoimmune hemolytic anemia treated with rituximab.
Bourantas LK; Pappas G; Kapsali E; Gougopoulou D; Papamichail D; Bourantas KL
Ann Pharmacother; 2010 Oct; 44(10):1677-80. PubMed ID: 20823278
[TBL] [Abstract][Full Text] [Related]
20. Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report.
Annicchiarico BE; Siciliano M; Avolio AW; Agnes S; Bombardieri G
Transplant Proc; 2009 May; 41(4):1380-2. PubMed ID: 19460565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
